Robert Olstein's JNJ Position Overview
Robert Olstein (via Olstein Capital Management, L.P.) currently holds 24,500 shares of Johnson & Johnson (JNJ) worth $5.99 M, representing 1.31% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Robert Olstein has maintained a long-term strategic position in JNJ, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 26,000 shares. Largest reduction occurred in Q2 2017, reducing 29,000 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Olstein's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Robert Olstein
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -4,500 | Reduce 15.52% | 24,500 | $244.45 |
| Q4 2025 | -19,500 | Reduce 40.21% | 29,000 | $206.97 |
| Q3 2025 | -12,500 | Reduce 20.49% | 48,500 | $185.42 |
| Q1 2025 | -4,000 | Reduce 6.15% | 61,000 | $165.84 |
| Q4 2024 | +4,000 | Add 6.56% | 65,000 | $144.62 |
| Q2 2024 | +1,000 | Add 1.67% | 61,000 | $146.16 |
| Q1 2023 | +12,000 | Add 25.00% | 60,000 | $155.00 |
| Q4 2022 | -10,000 | Reduce 17.24% | 48,000 | $176.65 |
| Q3 2022 | -3,000 | Reduce 4.92% | 58,000 | $163.36 |
| Q2 2022 | -10,000 | Reduce 14.08% | 61,000 | $177.51 |
| Q4 2021 | +7,000 | Add 10.94% | 71,000 | $171.07 |
| Q1 2021 | +19,000 | Add 42.22% | 64,000 | $164.34 |
| Q4 2020 | +11,000 | Add 32.35% | 45,000 | $157.38 |
| Q3 2020 | +8,000 | Add 30.77% | 34,000 | $148.88 |
| Q2 2020 | +26,000 | New Buy | 26,000 | $140.62 |
| Q2 2017 | -29,000 | Sold Out | 0 | $0.00 |
| Q4 2016 | -1,000 | Reduce 3.33% | 29,000 | $115.21 |
| Q3 2016 | -11,000 | Reduce 26.83% | 30,000 | $118.13 |
| Q2 2016 | -9,000 | Reduce 18.00% | 41,000 | $121.29 |
| Q1 2016 | -21,000 | Reduce 29.58% | 50,000 | $108.20 |
| Q4 2014 | -12,000 | Reduce 14.46% | 71,000 | $104.56 |
| Q3 2014 | -4,000 | Reduce 4.60% | 83,000 | $106.59 |
| Q2 2014 | -23,000 | Reduce 20.91% | 87,000 | $104.62 |
| Q1 2014 | +19,000 | Add 20.88% | 110,000 | $98.23 |
| Q4 2013 | -1,000 | Reduce 1.09% | 91,000 | $91.59 |
| Q3 2013 | +2,000 | Add 2.22% | 92,000 | $86.68 |
| Q2 2013 | +90,001 | Add 0.00% | 90,000 | $85.86 |
Robert Olstein's Johnson & Johnson Investment FAQs
Robert Olstein first purchased Johnson & Johnson (JNJ) in Q2 2013, acquiring 90,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein has held Johnson & Johnson (JNJ) for 41 quarters since Q2 2013.
Robert Olstein's largest addition to Johnson & Johnson (JNJ) was in Q2 2013, adding 90,000 shares worth $7.73 M.
According to the latest 13F filing for Q1 2026, Robert Olstein's firm, Olstein Capital Management, L.P., owns 24,500 shares of Johnson & Johnson (JNJ), valued at approximately $5.99 M.
As of the Q1 2026 filing, Johnson & Johnson (JNJ) represents approximately 1.31% of Robert Olstein's publicly disclosed stock portfolio, making it one of their key holdings.
Robert Olstein's peak holding in Johnson & Johnson (JNJ) was 110,000 shares, as reported at the end of Q1 2014.